Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 7/20 | 0.50 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.46 |
| ▸ | SNCA | P37840 | 1/20 | 0.46 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.46 |
| ▸ | CTSL | P07711 | 1/20 | 0.46 |
| ▸ | CTSB | P07858 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | DPP4 | P27487 | 7/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7186253 | 1.00 | ABCG2 (0.53) | ABCG2PTPN1CAPN1SNCATNFRSF1A | |
| SCHEMBL7187253 | 0.92 | ABCG2 (0.56) | ABCG2PTPN1CAPN1SNCATNFRSF1A | |
| SCHEMBL7187255 | 0.92 | ABCG2 (0.56) | ABCG2PTPN1CAPN1SNCATNFRSF1A | |
| SCHEMBL7180253 | 0.91 | ABCG2 (0.59) | ABCG2PTPN1CAPN1SNCATNFRSF1A | |
| SCHEMBL7180245 | 0.91 | ABCG2 (0.59) | ABCG2PTPN1CAPN1SNCATNFRSF1A | |
| SCHEMBL7179754 | 0.84 | ABCG2 (0.60) | ABCG2PTPN1CAPN1SNCATNFRSF1A | |
| SCHEMBL7179752 | 0.84 | ABCG2 (0.60) | ABCG2PTPN1CAPN1SNCATNFRSF1A | |
| SCHEMBL7190280 | 0.82 | ABCG2 (0.55) | ABCG2PTPN1CAPN1SNCATNFRSF1A | |
| SCHEMBL7192399 | 0.81 | LMNA (0.46) | ABCG2PTPN1DPP4 | |
| SCHEMBL7192400 | 0.81 | LMNA (0.46) | ABCG2PTPN1DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6603046-B1 | The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. | LICA PHARMACEUTICALS A/S (DK) | 2003-08-05 | — | — | US | disclosed |
| EP-0634927-B1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | LICA PHARMACEUTICALS AS (DK) | 2001-07-04 | — | — | EP | disclosed |
| US-5985935-A | PARASITICIDES OR BACTERICIDES | STATENS SERUMINSTITUT (DK) | 1999-11-16 | — | — | US | disclosed |
| EP-0634927-A1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | STATENS SERUMINSTITUT (DK) | 1995-01-25 | — | — | EP | disclosed |
| WO-1993017671-A1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | STATENS SERUMINSTITUT (DK) | 1993-09-16 | — | — | WO | disclosed |